SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

NCT00095992 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

NETWORK

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: ispinesib

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]